Nominees for best AbbVie blunder in the last 10 years are…

[anonymous]

Why? Why not the entire R&D due diligence team? Why not the AbbVie incompetent R&D leaders who devalued and eventually lost the CNS experts they acquired from Allergan who are responsible for their current commercial pipeline? Why not the decision makers who allow R&D to continue to fester in mediocrity (at best). Why not the legacy Allergan leaders who knew the space and the teams at other companies and didn’t advocate for say Karuna? Pretty sure a few people knew the former CEO and his track record in CNS.

ND is trying to fill these gaps but he cant do it alone. It’s a Phase 2 failure. This lies at the feet of R&D and a few commercial leaders who should have led.

I already shit on this company's stupid botox play.

 

[anonymous]

Where are the other vraylar indications?

 

[anonymous]

Why? Why not the entire R&D due diligence team? Why not the AbbVie incompetent R&D leaders who devalued and eventually lost the CNS experts they acquired from Allergan who are responsible for their current commercial pipeline? Why not the decision makers who allow R&D to continue to fester in mediocrity (at best). Why not the legacy Allergan leaders who knew the space and the teams at other companies and didn’t advocate for say Karuna? Pretty sure a few people knew the former CEO and his track record in CNS.

ND is trying to fill these gaps but he cant do it alone. It’s a Phase 2 failure. This lies at the feet of R&D and a few commercial leaders who should have led.

Wow! Strange. Didn't ND get a fat bonus check along with his cronies for an M&A delivered.... same team should be held accountable too..all those folks in the CBSO...